Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DorsaViASX:DVL Equity-to-Asset is 0.74 as of Dec. 2025, which is 17% above its 10-year median of 0.63. The stock has 4 warning signs investors should review. Among 2,498 Hardware companies, DorsaVi ranks better than 77.5% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. DorsaVi's Total Stockholders Equity for the quarter that ended in Dec. 2025 was A$5.99 Mil. DorsaVi's Total Assets for the quarter that ended in Dec. 2025 was A$8.13 Mil.
Therefore, DorsaVi's Equity to Asset Ratio for the quarter that ended in Dec. 2025 was 0.74.
The historical rank and industry rank for DorsaVi's Equity-to-Asset or its related term are showing as below:
ASX:DVL'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.12 Med: 0.63 Max: 0.92
Current: 0.74
During the past 12 years, the highest Equity to Asset Ratio of DorsaVi was 0.92. The lowest was 0.12. And the median was 0.63.
ASX:DVL's Equity-to-Asset is ranked better than 77.5% of 2498
companies
in the Hardware industry
Industry Median: 0.57
vs ASX:DVL: 0.74
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
DorsaVi Equity-to-Asset Related Terms
DorsaVi Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for DorsaVi's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:DVL vs COHR, KEYS, GRMN: Equity-to-Asset Comparison
For the Scientific & Technical Instruments subindustry, DorsaVi's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DorsaVi Equity-to-Asset vs Hardware Industry
For the Hardware industry and Technology sector, DorsaVi's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where DorsaVi's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
DorsaVi's Equity to Asset Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DorsaVi (ASX:DVL) has a Equity-to-Asset of 0.74 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on DorsaVi and its competitors. This is 17% above median its historical median of 0.63. Over the past decade, DorsaVi's Equity-to-Asset has ranged from 0.12 to 0.92. According to the industry distribution chart, DorsaVi ranks #562 out of 2498 companies in the Hardware industry, placing it in the top 22.5%.
Is DorsaVi's Equity-to-Asset too high?
DorsaVi's current Equity-to-Asset of 0.74 is 17% above median its 10-year median of 0.63. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 0.92. The Hardware industry median Equity-to-Asset is 0.57. DorsaVi's value of 0.74 is 29.8% above this industry median. Based on the distribution chart, DorsaVi ranks #562 out of 2498 companies in the Hardware industry, which is in the top quartile — a strong position relative to peers.
How does DorsaVi's Equity-to-Asset compare to COHR and KEYS?
According to the Hardware industry distribution chart, DorsaVi ranks #562 out of 2498 companies for Equity-to-Asset. This places DorsaVi in the top 23% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.57. DorsaVi's value of 0.74 is 29.8% above this benchmark. Historically, DorsaVi's own Equity-to-Asset has ranged from 0.12 to 0.92 over the past decade. While the company's 10-year median is 0.63 vs. the industry median of 0.57, DorsaVi has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Hardware company?
The median Equity-to-Asset among Hardware companies is 0.57, based on 2,498 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DorsaVi's current Equity-to-Asset of 0.74 is 29.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on DorsaVi and its competitors. For the Hardware industry, the median Equity-to-Asset is 0.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DorsaVi's current Equity-to-Asset is 0.74, which is 17% above median its own 10-year median of 0.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DorsaVi stock overvalued right now?
DorsaVi (ASX:DVL) has a current Equity-to-Asset of 0.74. The current Equity-to-Asset is 0.74, which is 17% above median its 10-year median of 0.63 and 29.8% above the Hardware industry median of 0.57. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For DorsaVi (ASX:DVL), the current Equity-to-Asset is 0.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
DorsaVi Ltd is engaged in the development and sale of motion analysis technologies. Its technologies are commercialized via license, sale, or fixed-fee consultancy. The company makes wearable sensors, software, and sophisticated algorithms that measure movement and muscle activation at around 200 frames per second. The company's products include ViSafe (Workplace), ViMove (Clinic), and others. The firm operates in two reportable segments: Clinical and Workplace. The majority of its revenue is generated from the Clinical segment. Geographically, the company derives maximum revenue from the United States of America, and the rest from Australia and Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:DVL has been successfully added to your 
